Ausgabe 4/2019
Inhalt (25 Artikel)
MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort
Ying X. Gue, Natasha Corballis, Alisdair Ryding, Juan Carlos Kaski, Diana A. Gorog
Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018
Nayyra Fatani, Christopher Fanikos, Clara Ting, Leo F. Buckley, John Fanikos
Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement
Ioannis Liampas, Antonios Chlinos, Vasileios Siokas, Alexandros Brotis, Efthimios Dardiotis
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
Dominick J. Angiolillo, Deepak L. Bhatt, Frank Lanza, Byron Cryer, Jin-fei Dong, Walter Jeske, Ronald R. Zimmerman, Estela von Chong, Jayne Prats, Efthymios N. Deliargyris, Upendra Marathi
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, Lars Wallentin, Stefan K. James, Andrzej Budaj, Hugo A. Katus, Anders Himmelmann, Kurt Huber, Agneta Siegbahn, Robert F. Storey, Richard C. Becker
Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy
Jessica L. Cohen, Elena Thompson, Liron Sinvani, Andrzej Kozikowski, Guang Qiu, Renee Pekmezaris, Alex C. Spyropoulos, Jason J. Wang
Interhospital transfer on intravenous thrombolysis in patients with acute ischemic stroke in three chinese municipal stroke centers
Yunlong Ding, Zhanyi Ji, Li Ma, Tingting Zhai, Zhiqun Gu, Jiali Niu, Yan Liu
Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry
Yuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, Syunsuke Saga, Hidewo Amano, Toru Takase, Seiichi Hiramori, Kitae Kim, Maki Oi, Masaharu Akao, Yohei Kobayashi, Mamoru Toyofuku, Toshiaki Izumi, Tomohisa Tada, Po-Min Chen, Koichiro Murata, Yoshiaki Tsuyuki, Tomoki Sasa, Jiro Sakamoto, Minako Kinoshita, Kiyonori Togi, Hiroshi Mabuchi, Kensuke Takabayashi, Yusuke Yoshikawa, Hiroki Shiomi, Takao Kato, Takeru Makiyama, Koh Ono, Yukihito Sato, Takeshi Kimura
Assessing patient preferences for switching from warfarin to direct oral anticoagulants
Jack N. Wright, Sara R. Vazquez, Kibum Kim, Aubrey E. Jones, Daniel M. Witt
Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study
Maciej Wiktor Polak, Jakub Siudut, Krzysztof Plens, Anetta Undas
Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement
Kajetan Grodecki, Karol Zbroński, Elżbieta Przybyszewska-Kazulak, Anna Olasińska-Wiśniewska, Radosław Wilimski, Bartosz Rymuza, Piotr Scisło, Paweł Czub, Dominika Koper, Janusz Kochman, Katarzyna Pawlak, Olga Ciepiela, Marek Grygier, Marek Jemielity, Maciej Lesiak, Krzysztof J. Filipiak, Grzegorz Opolski, Zenon Huczek
Apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement?
Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jakub Benko, Ján Staško, Peter Kubisz, Peter Galajda, Marián Mokán
Description of anti-Xa monitoring practices during low molecular weight heparin use
Albert Lin, Sara R. Vazquez, Aubrey E. Jones, Daniel M. Witt
Survey of confidence in use of stroke and bleeding risk calculators, knowledge of anticoagulants, and comfort with prescription of anticoagulation in challenging scenarios: SUPPORT-AF II study
Azraa Amroze, Kathleen Mazor, Sybil Crawford, Kevin O’Day, David D. McManus, Alok Kapoor
A narrative review of red blood cell distribution width as a marker for pulmonary embolism
Lindsay Hammons, Jason Filopei, David Steiger, Eric Bondarsky
Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG)
Yu Mou, Mao Li, Shengzhong Hou, Xue Ren, Bole Tian
Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings
Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, Sanghun Iwashiro, Yoko Kidani, Yutaka Okayama, Toshiyuki Sunaya, Shoichiro Sato, Satoshi Yamanaka
Ticagrelor after pharmacological thrombolysis in patients with ST-segment elevation myocardial infarctions: insight from a trial sequential analysis
Mohammed Osman, Babikir Kheiri, Amanda Jo Shigle, Maryam Saleem, Khansa Osman, Partho P. Sengupta, Jason A. Moreland
Venous thromboembolism 2011–2018 in Stockholm: a demographic study
Per Wändell, Tomas Forslund, Helene Danin Mankowitz, Anna Ugarph-Morawski, Staffan Eliasson, Frieder Braunschwieg, Margareta Holmström
Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency
A. Moret, Ángel Zúñiga, M. Ibáñez, A. R. Cid, S. Haya, F. Ferrando, A. Blanquer, J. Cervera, S. Bonanad
Intravenous thrombolysis in acute ischemic stroke due to intracranial artery dissection: a single-center case series and a review of literature
Francisco Bernardo, Stefania Nannoni, Davide Strambo, Bruno Bartolini, Patrik Michel, Gaia Sirimarco
The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin
Pall T. Onundarson, Brynja R. Gudmundsdottir
First evidence for a pharmacist-led anticoagulant clinic in a medicare part A long term care environment
Jeffrey A. Gray, Ralph A. Lugo, Vivi N. Patel, Cindy J. Pohland, David W. Stewart
Ibrutinib related bleeding complications in elderly patients with B cell malignancies
Roberto Castelli, Riccardo Schiavon, Carlo Preti, Giorgio Lambertenghi Deliliers
Lethal concentrations of mercury or lead do not affect coagulation kinetics in human plasma
Vance G. Nielsen